Publication number: 20190145962
Abstract: Provided is a peptide having an ability to inhibit binding between amylospheroids (ASPD) and neurons. In one aspect, provided is a synthesized, isolated, or purified polypeptide represented by Formula (I) or (II) below: X1X2X3X4 (I), where X1 is R, H, or K, X2 is R, K, D, H, W, Q, Y, or T, X3 is any amino acid, and X4 is W, F, or Y; and X1X2X3X4 (II), where X1 is R, H, or K, X2 is any amino acid, X3 is L, G, I, W, R, M, D, E, A, V, or K, and X4 is W, F, or Y.
Type:
Application
Filed:
April 13, 2017
Publication date:
May 16, 2019
Applicant:
TAO HEALTH LIFE PHARMA CO., LTD.
Inventors:
Minako HOSHI, Tomoya SASAHARA, Eri SAIJYO, Genji IWASAKI, Ichiro MORI
